← FDA Drug Approvals (Drugs@FDA)
ETCAMAH
NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2026-09-04
Drug application
- FDA Application #
NDA220359- Application type
- New Drug Application
- Brand name
- ETCAMAH
- Generic name
- CAMIZESTRANT
- Active ingredients
- CAMIZESTRANT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2026-09-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown